MOTIV Bioresorbable Scaffold in Below-The-Knee Artery Disease: European Post-Market Pilot BTK Trial: 36-Month Results
Andrej Schmidt, Michel Bosiers, Nasser Malyar, Raman Uberoi et al.
Citations
3 citations
Journal
CardioVascular and Interventional Radiology
Topics
Peripheral Artery Disease Management
Field-Weighted Citation Impact (FWCI)
6.02
article
MOTIV Bioresorbable Scaffold in Below-The-Knee Artery Disease: European Post-Market Pilot BTK Trial: 36-Month Results
Andrej Schmidt, Michel Bosiers, Nasser Malyar, Raman Uberoi, Dierk Scheinert, Henrik Schrøeder, Thomas Rand
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
CardioVascular and Interventional RadiologyVol. 48(11)
Institutions
University Hospital of Bern (CH), John Radcliffe Hospital (GB), Institute for Interdisciplinary Studies of Austrian Universities (AT), University Hospital Münster (DE), University Hospital Leipzig (DE), Oxford University Hospitals NHS Trust (GB), St. Franziskus Hospital (DE), Karl Landsteiner Society (AT), Jewish Hospital (US)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
MOTIV Bioresorbable Scaffold in Below-The-Knee Artery Disease: European Post-Market Pilot BTK Trial: 36-Month Results — Andrej Schmidt, Michel Bosiers, et al. · CardioVascular and Interventional Radiology (2025) | TGRS Research Map | TGRS